Skip to main content
. 2023 Mar 3;102(9):e33109. doi: 10.1097/MD.0000000000033109

Table 5.

Summary of adverse events for all subjects.

Sub code-/group Adverse event description Start date End date SAE? Severity Plausible relation to study drug Outcome
032–B coagulans Acidity October 24, 2020 October 24, 2020 No Mild No Resolved
032–B coagulans Vomiting October 27, 2020 October 27, 2020 No Mild No Resolved
032–B coagulans Acidity November 03, 2020 November 03, 2020 No Mild No Resolved

A total of 70 subjects were enrolled and 66 subjects completed the study. One subject in B coagulans group reported mild adverse event which was resolved within a day.

SAE = serious adverse event.